Trial Site Detail

 

Drug:
Imatinib + Dovitinib
Trial:
Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Withdrawn

 

Asan Medical center

     
Seoul , Songpa-gu 138-736
Republic of Korea

 

Principal Investigator:
Yoon-Koo Kang, PhD
Contact:
Activation Status of this Site:
Not yet activated
Notes about this Site:
Asan Medical center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.